Leukemia, 0887-6924

Journal

Publications

  1. 2019
  2. Published
  3. Published

    CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex

    Giacomo Volpe, Jon Frampton, 24 Jan 2019, In : Leukemia. 33, p. 1608-1619 12 p.

    Research output: Contribution to journalArticle

  4. 2018
  5. Published
  6. Published
  7. Published
  8. E-pub ahead of print

    The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia

    Pamela Kearns, 20 Mar 2018, In : Leukemia. 10 p.

    Research output: Contribution to journalArticle

  9. 2017
  10. Published
  11. Published
  12. Published
  13. 2016
  14. E-pub ahead of print
  15. E-pub ahead of print
  16. Published
  17. Published
  18. 2015
  19. E-pub ahead of print
  20. Published
  21. Published

    The impact of SF3B1 mutations in CLL on the DNA-damage response

    Ceri Oldreive, Tatjana Stankovic, May 2015, In : Leukemia. 29, 5, p. 1133-42 10 p.

    Research output: Contribution to journalArticle

  22. Published
  23. Published
  24. Published
  25. 2014
  26. Published
  27. Published

    A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia

    Pierre Cauchy, Peter Cockerill, Jul 2014, In : Leukemia. 28, 7, p. 1570-1572 3 p.

    Research output: Contribution to journalLetter

  28. Published

    Delineating MEIS1 cis-regulatory elements active in hematopoietic cells

    Conny Bonifer, Peter Cockerill, Feb 2014, In : Leukemia. 28, 2, p. 433-436 4 p.

    Research output: Contribution to journalLetter

  29. Published

    IMWG consensus on risk stratification in multiple myeloma

    Keith Wheatley, Feb 2014, In : Leukemia. 28, 2, p. 269-77 9 p.

    Research output: Contribution to journalArticle

  30. 2013
  31. Published

    Novel therapies for children with acute myeloid leukaemia

    Pamela Kearns, 1 Jul 2013, In : Leukemia. 27, 7, p. 1451-1460 10 p.

    Research output: Contribution to journalArticle

  32. Published

    C/EBPα and MYB regulate FLT3 expression in AML

    Giacomo Volpe, Paloma Garcia, Emilie Dasse, Laura O'Neill, Jon Frampton & Stephanie Dumon, 23 Jan 2013, In : Leukemia. 27, 7, p. 1487-1496 10 p.

    Research output: Contribution to journalArticle

  33. Published
  34. 2012
  35. Published
  36. Published
  37. Published

    Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage

    Victoria Weston, Tatjana Stankovic, 1 Apr 2012, In : Leukemia. 26, 4, p. 826-830 5 p.

    Research output: Contribution to journalArticle

  38. Published
  39. Published
  40. Published
  41. 2011
  42. Published

    The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome

    Keith Wheatley, 1 Jul 2011, In : Leukemia. 25, 7, p. 1122-1127 6 p.

    Research output: Contribution to journalArticle

  43. Published
  44. 2010
  45. Published
  46. Published
  47. Published
  48. Published

    Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma

    Jo Bradwell, 1 Aug 2010, In : Leukemia. 24, 8, p. 1498-1505 8 p.

    Research output: Contribution to journalArticle

  49. Published
  50. Published

    Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia

    & 2 others, Dickens Pratt, 1 Apr 2010, In : Leukemia. 24, 4, p. 877-881 5 p.

    Research output: Contribution to journalArticle

  51. 2009
  52. Published
  53. Published
  54. Published
  55. Published

    A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin

    Michael Griffiths, 1 Mar 2009, In : Leukemia. 23, 3, p. 614-617 4 p.

    Research output: Contribution to journalArticle

  56. Published
  57. Published
  58. 2008
  59. Published
  60. 2007
  61. Published
  62. 2006
  63. Published

    The role of the bax gene polymorphism G(-248)A in chronic lymphocytic leukaemia

    Dickens Pratt, 8 Jun 2006, In : Leukemia. 20, p. 1460-1461 2 p.

    Research output: Contribution to journalLetter

  64. Published
  65. 2005
  66. Published

    Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

    Keith Wheatley, Robert Hills, 1 Dec 2005, In : Leukemia. 19, p. 2130-2138 9 p.

    Research output: Contribution to journalArticle

  67. Published
  68. Published

    Acquired disomy for chromosome 13 is common in AML and associated with FLT3-itd mutations

    Charles Craddock, 20 Oct 2005, In : Leukemia. 19, p. 2355-2358 4 p.

    Research output: Contribution to journalArticle

  69. Published
  70. Published
  71. 2003
  72. Published

    Prenatal origin of hyperdiploid acute lymphoblastic leukemia in identical twins

    Michael Griffiths, 1 Nov 2003, In : Leukemia. 17, 11, p. 2202-2206 5 p.

    Research output: Contribution to journalArticle

  73. Published
  74. 2002
  75. Published
  76. Published
  77. 2001
  78. Published

    Inappropriate reporting and interpretation of subgroups in the AML-BFM 93 study

    Keith Wheatley & Robert Hills, 1 Nov 2001, In : Leukemia. 15, 11, p. 1803-1804 2 p.

    Research output: Contribution to journalArticle

  79. 2000
  80. Published

    A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation

    Charles Craddock, 2000, In : Leukemia. 14, 11, p. 1954-1959 6 p.

    Research output: Contribution to journalArticle

  81. 1994
  82. Published
  83. 1992
  84. Published